LISATA THERAPEUTICS, INC. Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
LISATA THERAPEUTICS, INC. (LSTA) reported Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) of $0 for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill · last filed 2016-11-07
- LISATA THERAPEUTICS, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2016-09-30 was $0.00.
- LISATA THERAPEUTICS, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2015-09-30 was $0.00.
- LISATA THERAPEUTICS, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2015-06-30 was $9.40M.
| Period end | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 3 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 6 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 9 month |
|---|---|---|---|
| 2016-09-30 | $0.00 10-Q · filed 2016-11-07 | $0.00 derived: sum of 2 quarters · filed 2016-11-07 | $0.00 10-Q · filed 2016-11-07 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-09 | $0.00 10-Q · filed 2016-08-09 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-07 | $9.40M derived: sum of 2 quarters · filed 2016-11-07 | $9.40M 10-Q · filed 2016-11-07 |
| 2015-06-30 | $9.40M 10-Q · filed 2016-08-09 | $9.40M 10-Q · filed 2016-08-09 | |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-05 | $0.00 derived: sum of 2 quarters · filed 2015-11-05 | $0.00 10-Q · filed 2015-11-05 |
| 2014-06-30 | $0.00 10-Q · filed 2015-08-06 | $0.00 10-Q · filed 2015-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |